YOU ARE HERE: LAT HomeCollectionsOsteoporosis


July 26, 2008 | From Times Staff and Wire Reports
Amgen Inc. said its experimental osteoporosis drug denosumab reduced fractures in women with the bone-thinning disease in a study. The trial of 7,800 women with osteoporosis found that denosumab strengthened bones and reduced spinal and hip fractures, the Thousand Oaks-based company said.
July 23, 1987
The Southern California chapter of the Arthritis Foundation has awarded a $60,000 grant to UCLA endocrinologist Theodore Hahn for a study on rheumatoid arthritis and osteoporosis. Rheumatoid arthritis patients are at high risk at an early age for osteoporosis, a dangerous thinning of the bones, officials said.
May 24, 1999
May is National Osteoporosis Month. Here are some facts about the disease, which is characterized by low bone mass and structural deterioration of bone tissue, which leads to bone fragility and an increased susceptibility to hip, spine and wrist fractures. * It's a major public health threat for an estimated 28 million Americans, 80% of whom are women. In the U.S., 10 million people have the disease and 18 million have low bone mass, putting them at risk for osteoporosis.
August 31, 2000
Fosamax, a drug widely used to prevent brittle bones in women, can help strengthen men's bones as well, researchers report in today's New England Journal of Medicine. Dr. Eric Orwoll of the Oregon Health Sciences University and his team found that men who took the drug, whose generic name is alendronate, instead of a placebo had significant increases in the density of their spine and hip bones.
April 20, 2000 | Dow Jones
The Food and Drug Administration cleared a Beckman Coulter Inc. blood test as an aid in managing osteoporosis and Paget's disease, the Fullerton company said Wednesday. The new Access Ostase test gives physicians and patients a more timely method to evaluate therapy to help prevent or treat osteoporosis, a disease that weakens the bones, and Paget's disease, a crippling bone disorder, the company said. The company's stock closed Wednesday at $63.
October 12, 1995 | SHARI ROAN
What's new in the treatment of osteoporosis? * Fosamax. Approved last week, Fosamax is the first new drug for osteoporosis in 20 years. The drug, chemically known as alendronate, helps to increase bone density. * Calcitonin nasal spray. The hormone calcitonin, now available as an injectable medication, may soon be approved as a nasal spray. The medication helps slow the rate of bone loss. * Sodium fluoride.
December 16, 2002 | Shari Roan, Times Staff Writer
Imagine going to the doctor's office once a year for treatment of a chronic medical condition. No daily pills. No weekly therapies. Just 30 minutes or so in a clinic. It could happen. A new osteoporosis drug called zoledronic acid has been shown to increase bone mineral density in rates similar to those achieved with medications taken daily or weekly.
Los Angeles Times Articles